Viewing Study NCT05998993


Ignite Creation Date: 2025-12-25 @ 1:21 AM
Ignite Modification Date: 2025-12-25 @ 11:30 PM
Study NCT ID: NCT05998993
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-08-21
First Post: 2023-07-28
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study to Evaluate SBRT for EGFR Mutant NSCLC Patients Receiving Osimertinib (CULTRO)
Sponsor: Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module